Hypercoagulability in critically ill patients with COVID 19, an observational prospective study.
Laure CalvetFrançois ThouyOlivier MascleAnne-Françoise SapinKévin GrapinJean Mathias LiteaudonBertrand EvrardBenjamin BonnetMireille AddaBertrand SouweineClaire DupuisPublished in: PloS one (2022)
Our study confirmed that most COVID-19 ICU patients have hypercoagulability on admission and almost all on day 4. Hyperfibrinogenemia or fibrinolysis shutdown on day 4 were associated with unfavorable outcome.